MedPath

Single and Multiple Dose Study of MK-1942 in Healthy Japanese Adults

Phase 1
Conditions
Alzheimer's Disease, Treatment-Resistant Depression
Registration Number
JPRN-jRCT2031210214
Lead Sponsor
Tanaka Yoshiyuki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
48
Inclusion Criteria

Healthy male aged 20 to 45 years old with BMI 18.5 to 25.0 kg/m2

Exclusion Criteria

Has a history of clinically significant abnormalities or diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath